Enterobacter
Background
Antibiotic Sensitivities[1]
| Enterobacter sp, AmpC neg | Enterobacter sp, AmpC pos |
| R | R |
| R | R |
| R | R |
| R | R |
| R | R |
| R | R |
| R | R |
| R | R |
| S | S |
| S | S |
| S | S |
| S | S |
| S | S |
| S | S |
| S | S |
| S | S |
| S | S |
| S | S |
| S | S |
| S | S |
| S | S |
| S | S |
| S | S |
| S | S |
| R | R |
| I | R |
| R | R |
| I | R |
| S | R |
| S | R |
| S | R |
| S | R |
| S | R |
| S | R |
| R | R |
| R | R |
| R | R |
| R | R |
| R | R |
| R | R |
| I | R |
| R | R |
| S | S |
| S | S |
| S | S |
| R | R |
| R | R |
| R | R |
| R | R |
| R | R |
| R | R |
| R | R |
| R | R |
| S | S |
| R | R |
| R | R |
| R | R |
| R | R |
| R | R |
| I | I |
| X1 | X1 |
| I | I |
| S | S |
| R | R |
| R | R |
| R | R |
| R | R |
| S | S |
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
Table Overview
| ||||||||||||||||||||||||||||||||||||||||
See Also
References
- ↑ Sanford Guide to Antimicrobial Therapy 2014